S
Shai Melcer
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
Oct 1, 2026
Bioconvergence & future human health, with Shai Melcer
9:05

Nicole RaleighHOST
Can you give us some sort of tastes of the case studies there for listeners and also be sort of, I don't know, more specific about the Israel Innovation Authority's specific efforts in this space?
S
9:25Shai MelcerGUEST
There are different sub-sectors or different inner worlds in bioconvergence, which again is a tech approach as opposed to the different markets that they cater to like health, food, agri and others.
S
9:45Shai MelcerGUEST
These are companies in which the engineering platform on which you place biological material and then run certain types of processes and collect certain types of data, that's the common denominator, but they do it in different worlds.
S
10:01Shai MelcerGUEST
So if we take a company like Teracyte, for instance, Teracyte built a biochip.
10 MINS LATER